CN102018930A - Medicine composition for treating hepatitis B - Google Patents

Medicine composition for treating hepatitis B Download PDF

Info

Publication number
CN102018930A
CN102018930A CN2009101746812A CN200910174681A CN102018930A CN 102018930 A CN102018930 A CN 102018930A CN 2009101746812 A CN2009101746812 A CN 2009101746812A CN 200910174681 A CN200910174681 A CN 200910174681A CN 102018930 A CN102018930 A CN 102018930A
Authority
CN
China
Prior art keywords
grams
radix
treatment
rhizoma
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009101746812A
Other languages
Chinese (zh)
Inventor
张志通
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009101746812A priority Critical patent/CN102018930A/en
Publication of CN102018930A publication Critical patent/CN102018930A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine composition for treating hepatitis B, comprising the following components: 10 g of Chinese rhubarb, 15 g of wenchow turmeric root tuber, 10 g of bupleurum falcatum, 15 g of baical skullcap root, 15 g of giant knot weed, 15 g of spreading hedyotis herb, 20 g of oriental wormwood, 30 g of turtle shell, 20 g of roots of red-rooted salvia, 15 g of endothelium corneum gigeriae galli, 20 g of bighead atractylodes rhizome, 30 g of Chinese yam, 15 g of fruit of immature citron, 15 g of red ginseng, 40 g of astragalus mongholicus, 30 g of root of rehmannia, 10 g of antler glue, 15 g of Lonicera confuse, 15 g of cape jasmine fruit, 15 g of patrinia and 15 g of purslane. The medicinal herbs are pulverized and prepared into pills of 10 g by each, patients can take three pills each time for three times in one day, one course of treatment lasts for two months, and the patients need to take two courses of treatment to acquire a better treatment effect in general.

Description

The medicament composing prescription of treatment hepatitis B
Affiliated technical field
The present invention relates to a kind of medicament composing prescription for the treatment of hepatitis B, comprise the medicament composing prescription for the treatment of acute and chronic hepatitis B.
Background technology
Hepatitis B is covered by among the scope of motherland's medical science subcutaneous ulcer disease, its pathogenesis key is damp and hot heresy, again because touching difficult Yu of most patient, cause all empty disease characteristics of negative and positive of qi and blood to the patient, modern medicine study thinks that along with the progress of the course of disease, it is low gradually that immunologic function will appear in hepatitis B, even the appearance toleration, the adrenal cortex function that the have Clinical symptoms of tissue organ function's decay such as fade, have in addition hepatocyte occurs and cancerate.
Summary of the invention
The object of the present invention is to provide a kind of medicament composing prescription that is used for the treatment of acute and chronic hepatitis B evident in efficacy.
Medicament composing prescription of the present invention is as follows:
Radix Et Rhizoma Rhei 10 grams, Radix Curcumae 15 grams, Radix Bupleuri 10 grams, Radix Scutellariae 15 grams, Rhizoma Polygoni Cuspidati 15 grams, Hedyotidis Diffusae 15 grams, Herba Artemisiae Scopariae 20 grams, Carapax Trionycis 30 grams, Radix Salviae Miltiorrhizae 20 grams, Endothelium Corneum Gigeriae Galli 15 grams, the Rhizoma Atractylodis Macrocephalae 20 grams, Rhizoma Dioscoreae 30 grams, Fructus Aurantii Immaturus 15 grams, Radix Ginseng Rubra 15 grams, the Radix Astragali 40 grams, the Radix Rehmanniae 30 grams, Colla cornus cervi 10 grams, Flos Lonicerae 15 grams, Fructus Gardeniae 15 grams, Herba Patriniae 15 grams, Herba Portulacae 15 grams, said medicine is according to dosage pulverized, make the pill of 10 grams, one time 3 ball, 3 times on the one, be a course of treatment February, take 2 courses of treatment, generally can receive curative effect preferably.
The specific embodiment
The medicine of above-mentioned prescription is according to dosage pulverized, made the pill of 10 grams, one time 3 ball, 3 times on the one, be a course of treatment February, takes 2 courses of treatment, generally can receive curative effect preferably.
In the side: Herba Artemisiae Scopariae, Fructus Gardeniae, Hedyotidis Diffusae clearing away heat-damp and promoting diuresis, diuresis makes damp and hot heresy separate from urine, and wherein, Hedyotidis Diffusae has antitumor action according to modern study, can prevent that hepatitis B from cancerating; Join the Fructus Aurantii Immaturus circulation of qi promoting painful abdominal mass that disappears under the Radix Et Rhizoma Rhei bitter cold is rushed down, can make damp and hotly to go out from stool, liver-gallbladder disease is the heresy of half exterior and half interior, and Radix Bupleuri is joined Radix Scutellariae can make its evil expeling, and in addition, Radix Bupleuri has hepatoprotective effect according to modern study, because damp and hot harmony is burnt in stagnating, causes the imbalance of taste ascending or descending movement of vital Qi; Obstacle takes place in suffocating of liver and gall, thereby two sides of body take place has a pain, and with Radix Curcumae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae circulation of qi promoting, blood circulation promoting and blood stasis dispelling, thereby changes the blood circulation state of liver; Endothelium Corneum Gigeriae Galli, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Radix Ginseng Rubra, the Radix Astragali, the Radix Rehmanniae, Colla cornus cervi, Carapax Trionycis all has digesting and appetizing, the effect of strengthening spleen, tonifying kidney, thereby correct the clinical picture of the every deterioration of hepatitis B patient, in addition, Radix Rehmanniae YIN nourishing and the production of body fluid promoting, it is of a specified duration to prevent that activating blood and removing stasis drug from using, excessively consume impairment of YIN blood, the Radix Astragali has the effect of free radical resisting according to modern medicine study, prevent that hepatocyte from cancerating, Carapax Trionycis can make the liver spleen of enlargement dwindle Flos Lonicerae, the Herba Portulacae heat reliving and toxin-eliminating, cooling blood for hemostasis, can prevent complicated hepatitis B patient hypofunction, easily suffer from respiratory tract infection, intestinal infection is for the hepatitis B patient rehabilitation creates conditions, in a word, originally can effectively treat various urgency, chronic viral hepatitis B.

Claims (1)

1. a medicament composing prescription for the treatment of hepatitis B is characterized in that: Radix Et Rhizoma Rhei 10 grams, Radix Curcumae 15 grams, Radix Bupleuri 10 grams, Radix Scutellariae 15 grams, Rhizoma Polygoni Cuspidati 15 grams, Hedyotidis Diffusae 15 grams, Herba Artemisiae Scopariae 20 grams, Carapax Trionycis 30 grams, Radix Salviae Miltiorrhizae 20 grams, Endothelium Corneum Gigeriae Galli 15 grams, the Rhizoma Atractylodis Macrocephalae 20 grams, Rhizoma Dioscoreae 30 grams, Fructus Aurantii Immaturus 15 grams, Radix Ginseng Rubra 15 grams, the Radix Astragali 40 grams, the Radix Rehmanniae 30 grams, Colla cornus cervi 10 grams, Flos Lonicerae 15 grams, Fructus Gardeniae 15 grams, Herba Patriniae 15 grams, Herba Portulacae 15 grams.
CN2009101746812A 2009-09-15 2009-09-15 Medicine composition for treating hepatitis B Pending CN102018930A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009101746812A CN102018930A (en) 2009-09-15 2009-09-15 Medicine composition for treating hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009101746812A CN102018930A (en) 2009-09-15 2009-09-15 Medicine composition for treating hepatitis B

Publications (1)

Publication Number Publication Date
CN102018930A true CN102018930A (en) 2011-04-20

Family

ID=43860980

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009101746812A Pending CN102018930A (en) 2009-09-15 2009-09-15 Medicine composition for treating hepatitis B

Country Status (1)

Country Link
CN (1) CN102018930A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085332A (en) * 2011-01-13 2011-06-08 冯安华 Medicament for treating early ascites due to cirrhosis
CN102764337A (en) * 2012-08-20 2012-11-07 马驰 Traditional Chinese medicine composition for curing hepatitis B

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085332A (en) * 2011-01-13 2011-06-08 冯安华 Medicament for treating early ascites due to cirrhosis
CN102085332B (en) * 2011-01-13 2012-08-22 冯安华 Medicament for treating early ascites due to cirrhosis
CN102764337A (en) * 2012-08-20 2012-11-07 马驰 Traditional Chinese medicine composition for curing hepatitis B
CN102764337B (en) * 2012-08-20 2014-04-09 马驰 Traditional Chinese medicine composition for curing hepatitis B

Similar Documents

Publication Publication Date Title
CN101637585B (en) Chinese herbal preparation for treating posirasis and preparation method thereof
CN1562160A (en) Composite medicine for treating hepatitis B complication
CN103341004A (en) Chinese medicine composition for treating delayed menstrual cycle
CN100400094C (en) Traditional Chinese medicine for treating hepatitis B and its preparing process
CN102512630A (en) Traditional Chinese medicine composition for treating gallbladder calculus
CN101716298B (en) Traditional Chinese medicine preparation for treating surgical intestinal adhesions
CN102512632B (en) Chinese herbal composition for treating abnormal menstruation
CN101987138A (en) Chinese medicinal preparation for treating impotence
CN1103223C (en) Chinese medicine for treating cholecystitis
CN102048900A (en) Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion
CN104173565A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN102018930A (en) Medicine composition for treating hepatitis B
CN102397431B (en) Appendicitis treating oral liquid
CN104173818A (en) Traditional Chinese medicine composition for treating calculus
CN101991797A (en) Medicine formula for treating Behcet's disease
CN101991747A (en) Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis
CN102327553A (en) Traditional Chinese medicine for treating pyogenic osteomyelitis
CN102641479B (en) Drug composite for treating hepatitis c
CN1332707C (en) Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B
CN1240415C (en) Tablets against allergic purpura
CN103006877B (en) Formula for systemic lupus erythematosus treatment drug
CN104958525A (en) Traditional Chinese medicine composition for treating chronic infectious arthritis and preparation method of traditional Chinese medicine composition
CN103610893A (en) Traditional Chinese medicine for treating coronary disease
CN102949658B (en) Drug formula for treating hepatitis
CN102614432B (en) Traditional Chinese medicine composition for treating cervicitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20110420